Multiple Sclerosis Market Size And Share

  • Report Code : TIPRE00004597
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Dimensioni, segmenti e analisi del mercato delle terapie per la sclerosi multipla entro il 2025-2031

Buy Now

Multiple Sclerosis Therapeutics Market Report Multiple Sclerosis Therapeutics Market Scope and Analysis Multiple Sclerosis Therapeutics Market Size and Share

Multiple Sclerosis Therapeutics Market: Strategic Insights

Multiple Sclerosis Therapeutics Market

  • CAGR (2025 - 2031)
    6.8%
  • Market Size 2024
    US$ 31.87 Billion
  • Market Size 2031
    US$ 53.77 Billion

Market Dynamics

GROWTH DRIVERS
  • Aumento della prevalenza della sclerosi multipla
  • Aumento dei lanci di prodotti
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • Aumento delle sovvenzioni per la ricerca

Key Players

  • Merck and CO Inc
  • Novartis AG
  • Bayer AG
  • Sanofi
  • Bristoll-Myers Squibb
  • Horizon Therapeutics
  • Teva Pharmaceuticals
  • Takeda Pharmaceuticals
  • F.Hoffmann-La Roche
  • Biogen

Regional Overview

  • Nord America
  • Europa
  • Asia-Pacifico
  • Sud e Centro America
  • Medio Oriente e Africa

Market Segmentation

Classe di farmaci
  • immunosoppressori
  • immunomodulatori
Via di somministrazione
  • iniettabile e orale
Canale di distribuzione
  • farmacie ospedaliere
  • farmacie al dettaglio
  • e-commerce